Loading...
Market
What will be the primary benefit of the new infant heart stent by 2025?
2
Resolution / Starting Odds
Reduced surgery count • 25%
Faster recovery times • 25%
Lower complication rates • 25%
Cost savings • 25%
Surveys or reports from hospitals and healthcare providers
Story
FDA Approves Less Invasive Heart Stent for Infants to Reduce Surgeries
Oct 17, 2024, 12:15 PM
The FDA recently approved a heart stent designed specifically for infants and young children. This device aims to help children born with congenital heart defects avoid a series of open heart surgeries throughout their childhood. Traditionally, children needing heart stents faced multiple open heart operations before reaching middle school. The new stent offers a less invasive treatment option, potentially reducing the number of surgeries required and addressing heart issues with less invasive procedures.
View original story
Similar markets
Increased patient survival rate • 25%
Improved quality of life • 25%
Reduced need for medication • 25%
Other • 25%
Faster recovery time • 25%
Reduced pain • 25%
Shorter hospital stay • 25%
Improved surgical precision • 25%
Reduced recovery time • 25%
Increased precision • 25%
Lower complication rates • 25%
Other • 25%
Increased precision • 25%
Reduced surgery time • 25%
Lower complication rates • 25%
Cost reduction • 25%
Increased surgical precision • 25%
Reduced surgery time • 25%
Improved patient outcomes • 25%
Enhanced training for surgeons • 25%
Mechanical failure • 25%
Patient immune response • 25%
Surgical complications • 25%
Other • 25%
Reduced bleeding risk • 25%
Improved patient compliance • 25%
Lower long-term costs • 25%
Other benefits • 25%
Improved diagnostic accuracy • 25%
Reduced diagnostic time • 25%
Cost savings • 25%
Improved patient satisfaction • 25%
Alzheimer's Disease • 25%
Parkinson's Disease • 25%
Schizophrenia • 25%
Other • 25%
Dietary changes • 25%
Increased physical activity • 25%
Smoking reduction • 25%
Improved medical treatments • 25%